{
  "abstract": "Background:: Optimal antiplatelet therapy after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) requires balancing thrombotic protection and bleeding risk, but the comparative effectiveness of current strategies remains uncertain.\n\nAims:: To evaluate the risk–benefit profile of oral antiplatelet strategies after PCI with DES, focusing on major bleeding and stent thrombosis.\n\nMethods:: A network meta-analysis of randomised and observational studies was conducted. Strategies included standard or extended dual antiplatelet therapy (DAPT), shortened DAPT followed by monotherapy and P2Y12 inhibitor-based monotherapy. Outcomes were analysed using a random-effects model and ranked with p-scores. Evidence certainty was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE).\n\nResults:: Thirty studies involving 110,035 patients were included. Ticagrelor monotherapy ranked highest for reducing major bleeding, whereas extended DAPT provided the greatest protection against stent thrombosis, with clopidogrel-based therapy beyond 12 months ranking highest (RR 0.08; 95% CI [0.01–0.52]; p-score=0.94). Notably, clopidogrel monotherapy after prolonged DAPT demonstrated a relatively balanced profile across both outcomes. However, no strategy was consistently optimal and most estimates showed wide CIs.\n\nConclusion:: Antiplatelet strategies after PCI with DES involve a clear trade-off between bleeding and thrombotic risk. Clopidogrel monotherapy after prolonged DAPT may offer a balanced approach, although findings should be interpreted cautiously due to limited precision and consistency.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Jember – Dr Soebandi General Hospital Jember, Indonesia",
    "Faculty of Medicine, Universitas Jember Jember, Indonesia",
    "Department of Epidemiology and Preventive Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University Kagoshima, Japan",
    "Kalisat General Hospital Jember, Indonesia"
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 9,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Suryono Suryono",
      "orcid": "0000-0001-9022-9674"
    },
    {
      "affs": [
        1
      ],
      "name": "Muhammad Farhan Hibatulloh",
      "orcid": "0009-0008-7711-8644"
    },
    {
      "affs": [
        1
      ],
      "name": "Alfiyah Ramadhani",
      "orcid": "0009-0000-1708-8115"
    },
    {
      "affs": [
        1
      ],
      "name": "Candra Agung Wibisana",
      "orcid": "0009-0007-1414-8339"
    },
    {
      "affs": [
        1
      ],
      "name": "Muhammad Naufal Hibatullah",
      "orcid": "0009-0008-5526-1992"
    },
    {
      "affs": [
        1,
        2
      ],
      "name": "Achmad Ilham Tohari",
      "orcid": "0000-0003-4465-2011"
    },
    {
      "affs": [
        1
      ],
      "name": "Muhammad Rijal Fahrudin Hidayat",
      "orcid": "0000-0002-5956-6805"
    },
    {
      "affs": [
        1
      ],
      "name": "Muhammad Irsyad Amien",
      "orcid": "0000-0002-5672-6957"
    },
    {
      "affs": [
        3
      ],
      "name": "Hazbina Fauqi Ramadhan",
      "orcid": "0000-0002-3562-3887"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6y59n79ep8qgj.bib",
  "cited_by": 0,
  "doi": "10.15420/ecr.2026.29",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13756551/",
  "id": "6y59n79ep8qgj",
  "issns": [
    "1758-3756",
    "1758-3764"
  ],
  "landing_url": "https://doi.org/10.15420/ecr.2026.29",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Intervention"
    ],
    [
      "openalex",
      "2705|Antiplatelet Therapy and Cardiovascular Diseases"
    ]
  ],
  "openalex": "W7224901007",
  "pdf_url": null,
  "pmcid": "PMC13756551",
  "pmid": "43022463",
  "published": "2026-10-30",
  "publisher": "Radcliffe Cardiology",
  "ris": "https://research.draconitic.com/paper/6y59n79ep8qgj.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:22:24Z",
      "native_id": "PMC13756551",
      "source": "pmc",
      "url": "https://doi.org/10.15420/ecr.2026.29"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2705|Antiplatelet Therapy and Cardiovascular Diseases",
      "subfield": "cardiovascular"
    }
  ],
  "title": "Risk–Benefit Profile of Oral Antiplatelet Strategies After Percutaneous Coronary Intervention with a Drug-eluting Stent: A Contemporary Network Meta-analysis of Major Bleeding and Stent Thrombosis Outcomes",
  "title_text": "Risk–Benefit Profile of Oral Antiplatelet Strategies After Percutaneous Coronary Intervention with a Drug-eluting Stent: A Contemporary Network Meta-analysis of Major Bleeding and Stent Thrombosis Outcomes",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:22:24Z",
  "url": "https://research.draconitic.com/paper/6y59n79ep8qgj",
  "venue": "European Cardiology Review",
  "versions": []
}